Differences in Epstein-Barr Virus Characteristics and Viral-Related Microenvironment Could Be Responsible for

Aldana Vistarop1, Oscar Jimenez1, Melina Cohen1

  • 1Multidisciplinary Institute for Investigation in Pediatric Pathologies (IMIPP), CONICET-GCBA. Molecular Biology Laboratory, Pathology Division, Ricardo Gutiérrez Children's Hospital, Buenos Aires C1425EFD, Argentina.

Insights

Epstein-Barr virus (EBV) infection in young children is linked to Hodgkin lymphoma (HL). Research shows specific EBV proteins and immune cells in pediatric HL, suggesting a role in lymphomagenesis.

Area of Science:

  • Pediatric Oncology
  • Virology
  • Immunology

Background:

  • Epstein-Barr virus (EBV) presence correlates with Hodgkin lymphoma (HL) in young Argentinian children.
  • Hodgkin lymphoma originates from germinal centers (GC), suggesting a link between EBV and GC biology.

Purpose of the Study:

  • To compare EBV protein expression and microenvironment markers in pediatric HL patients versus EBV-positive germinal centers (GC) in children.
  • Investigate the role of EBV in pediatric Hodgkin lymphoma pathogenesis.

Main Methods:

  • In situ hybridization and immunohistochemistry (IHC) were used to assess EBV presence and immune cell markers.
  • Analysis focused on viral latency patterns, protein co-expression (LMP1, LMP2), and immune cell infiltration (CD4+, IL10, CD68+).

Main Results:

  • Viral latency II pattern was observed in all pediatric HL patients and most EBV+ GCs.
  • LMP1 and LMP2 co-expression was significantly higher in HL cases compared to EBV+ GCs.
  • Increased CD4+, IL10, and CD68+ cells were found in EBV+ GCs, with higher IL10+ cells in EBV+ HL patients.

Conclusions:

  • LMP1 expression might be sufficient for neoplastic transformation in EBV-associated HL.
  • An immune-regulatory environment may counteract cytotoxic effects in EBV-associated HL.
  • CD4+ and CD68+ cells could collaboratively restrict EBV-mediated lymphomagenesis in tonsillar GCs.